These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 31428976)

  • 21. Clinical significance of epithelial-mesenchymal transition-associated markers in malignant pleural mesothelioma.
    Iwanami T; Uramoto H; Nakagawa M; Shimokawa H; Yamada S; Kohno K; Tanaka F
    Oncology; 2014; 86(2):109-16. PubMed ID: 24457449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apigenin causes necroptosis by inducing ROS accumulation, mitochondrial dysfunction, and ATP depletion in malignant mesothelioma cells.
    Lee YJ; Park KS; Nam HS; Cho MK; Lee SH
    Korean J Physiol Pharmacol; 2020 Nov; 24(6):493-502. PubMed ID: 33093271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sensitivity to epidermal growth factor receptor tyrosine kinase inhibitor requires E-cadherin in esophageal cancer and malignant pleural mesothelioma.
    Xin HW; Yang JH; Nguyen DM
    Anticancer Res; 2013 Jun; 33(6):2401-8. PubMed ID: 23749888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pan-inhibitor of Aurora kinases danusertib induces apoptosis and autophagy and suppresses epithelial-to-mesenchymal transition in human breast cancer cells.
    Li JP; Yang YX; Liu QL; Zhou ZW; Pan ST; He ZX; Zhang X; Yang T; Pan SY; Duan W; He SM; Chen XW; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():1027-62. PubMed ID: 25733818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trametinib plus 4-Methylumbelliferone Exhibits Antitumor Effects by ERK Blockade and CD44 Downregulation and Affects PD-1 and PD-L1 in Malignant Pleural Mesothelioma.
    Cho H; Matsumoto S; Fujita Y; Kuroda A; Menju T; Sonobe M; Kondo N; Torii I; Nakano T; Lara PN; Gandara DR; Date H; Hasegawa S
    J Thorac Oncol; 2017 Mar; 12(3):477-490. PubMed ID: 27867002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological targeting of p53 through RITA is an effective antitumoral strategy for malignant pleural mesothelioma.
    Di Marzo D; Forte IM; Indovina P; Di Gennaro E; Rizzo V; Giorgi F; Mattioli E; Iannuzzi CA; Budillon A; Giordano A; Pentimalli F
    Cell Cycle; 2014; 13(4):652-65. PubMed ID: 24345738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Licochalcone A induces apoptosis in malignant pleural mesothelioma through downregulation of Sp1 and subsequent activation of mitochondria-related apoptotic pathway.
    Kim KH; Yoon G; Cho JJ; Cho JH; Cho YS; Chae JI; Shim JH
    Int J Oncol; 2015 Mar; 46(3):1385-92. PubMed ID: 25586190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A molecular targeting against nuclear factor-κB, as a chemotherapeutic approach for human malignant mesothelioma.
    Nishikawa S; Tanaka A; Matsuda A; Oida K; Jang H; Jung K; Amagai Y; Ahn G; Okamoto N; Ishizaka S; Matsuda H
    Cancer Med; 2014 Apr; 3(2):416-25. PubMed ID: 24510578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth suppressive effect of pegylated arginase in malignant pleural mesothelioma xenografts.
    Lam SK; Li YY; Xu S; Leung LL; U KP; Zheng YF; Cheng PN; Ho JC
    Respir Res; 2017 May; 18(1):80. PubMed ID: 28464918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of Calretinin Expression in Human Mesothelioma Cells Reveals the Implication of the FAK and Wnt Signaling Pathways in Conferring Chemoresistance towards Cisplatin.
    Wörthmüller J; Salicio V; Oberson A; Blum W; Schwaller B
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31671889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In Vitro and In Vivo Antitumor Activity of [Pt(O,O'-acac)(γ-acac)(DMS)] in Malignant Pleural Mesothelioma.
    Muscella A; Vetrugno C; Cossa LG; Antonaci G; De Nuccio F; De Pascali SA; Fanizzi FP; Marsigliante S
    PLoS One; 2016; 11(11):e0165154. PubMed ID: 27806086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma.
    Villanova T; Gesmundo I; Audrito V; Vitale N; Silvagno F; Musuraca C; Righi L; Libener R; Riganti C; Bironzo P; Deaglio S; Papotti M; Cai R; Sha W; Ghigo E; Schally AV; Granata R
    Proc Natl Acad Sci U S A; 2019 Feb; 116(6):2226-2231. PubMed ID: 30659154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BA6 Induces Apoptosis via Stimulation of Reactive Oxygen Species and Inhibition of Oxidative Phosphorylation in Human Lung Cancer Cells.
    Cheng MH; Huang HL; Lin YY; Tsui KH; Chen PC; Cheng SY; Chong IW; Sung PJ; Tai MH; Wen ZH; Chen NF; Kuo HM
    Oxid Med Cell Longev; 2019; 2019():6342104. PubMed ID: 31205586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of autophagy potentiates pemetrexed and simvastatin-induced apoptotic cell death in malignant mesothelioma and non-small cell lung cancer cells.
    Hwang KE; Kim YS; Jung JW; Kwon SJ; Park DS; Cha BK; Oh SH; Yoon KH; Jeong ET; Kim HR
    Oncotarget; 2015 Oct; 6(30):29482-96. PubMed ID: 26334320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unique fractal evaluation and therapeutic implications of mitochondrial morphology in malignant mesothelioma.
    Lennon FE; Cianci GC; Kanteti R; Riehm JJ; Arif Q; Poroyko VA; Lupovitch E; Vigneswaran W; Husain A; Chen P; Liao JK; Sattler M; Kindler HL; Salgia R
    Sci Rep; 2016 Apr; 6():24578. PubMed ID: 27080907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of cytoplasmic p53 differentially modulates Ca(2+) signaling and cellular viability in young and aged striata.
    Ureshino RP; Hsu YT; do Carmo LG; Yokomizo CH; Nantes IL; Smaili SS
    Exp Gerontol; 2014 Oct; 58():120-7. PubMed ID: 25084214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-Methyl, N-propynyl-2-phenylethylamine (MPPE), a Selegiline Analog, Attenuates MPTP-induced Dopaminergic Toxicity with Guaranteed Behavioral Safety: Involvement of Inhibitions of Mitochondrial Oxidative Burdens and p53 Gene-elicited Pro-apoptotic Change.
    Shin EJ; Nam Y; Lee JW; Nguyen PT; Yoo JE; Tran TV; Jeong JH; Jang CG; Oh YJ; Youdim MBH; Lee PH; Nabeshima T; Kim HC
    Mol Neurobiol; 2016 Nov; 53(9):6251-6269. PubMed ID: 26563498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FGF2 and EGF induce epithelial-mesenchymal transition in malignant pleural mesothelioma cells via a MAPKinase/MMP1 signal.
    Schelch K; Wagner C; Hager S; Pirker C; Siess K; Lang E; Lin R; Kirschner MB; Mohr T; Brcic L; Marian B; Holzmann K; Grasl-Kraupp B; Krupitza G; Laszlo V; Klikovits T; Dome B; Hegedus B; Garay T; Reid G; van Zandwijk N; Klepetko W; Berger W; Grusch M; Hoda MA
    Carcinogenesis; 2018 Apr; 39(4):534-545. PubMed ID: 29635378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pivotal roles of p53 transcription-dependent and -independent pathways in manganese-induced mitochondrial dysfunction and neuronal apoptosis.
    Wan C; Ma X; Shi S; Zhao J; Nie X; Han J; Xiao J; Wang X; Jiang S; Jiang J
    Toxicol Appl Pharmacol; 2014 Dec; 281(3):294-302. PubMed ID: 25448048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The p53/HSP70 inhibitor, 2-phenylethynesulfonamide, causes oxidative stress, unfolded protein response and apoptosis in rainbow trout cells.
    Zeng F; Tee C; Liu M; Sherry JP; Dixon B; Duncker BP; Bols NC
    Aquat Toxicol; 2014 Jan; 146():45-51. PubMed ID: 24270669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.